Iain Ross BSc (Hons) Biochemistry, Chairman

Iain is an experienced business entrepreneur with more than 30 years experience in the pharmaceutical and biotechnology sector. From 2004 to 2010 he was Non-executive Chairman of Silence Therapeutics plc, the AIM-listed company, overseeing Silence's merger with the US company Intradigm Corporation in January 2010.

Between 1980 and1995 Iain held senior commercial positions with companies in the UK and internationally, including Sandoz AG, Fisons plc, Hoffmann-La Roche AG and Celltech Group Plc, where he was a main board director from 1991 to1995. Since 1995 he has undertaken and input to a number of biotech turnarounds and start-ups as a board member on behalf of banks and private equity groups. From 1995 to 2000 he was CEO of Quadrant Healthcare plc, and in 2001/2002 as Chairman and CEO he was responsible for the operational and financial turnaround of Allergy Therapeutics Ltd.

Iain has raised substantial funds both publicly and privately and has been involved in four Initial Public Offerings. He also has direct experience of mergers and acquisitions both in the UK and USA. He is currently Chairman of Biomer Technology Ltd and a Non-Executive Director of Powerstax Ltd.

Iain is a Chartered Director of the UK Institute of Directors, a Trustee of the Breast Cancer Haven and a member of the Council of Royal Holloway College, London University.